Business Wire

Datavault AI Appoints Shareholder and Investment Executive Jeffrey Tirman to the Board of Directors

14.10.2026 14:55:00 EEST | Business Wire | Press release

Share

Datavault AI Inc. (“Datavault AI” or the “Company”) (Nasdaq: DVLT), an Artificial Intelligence Platform (“AIP”) company providing data monetization, credentialing, and real-world asset (“RWA”) tokenization, today announced the appointment of Jeffrey Tirman to its Board of Directors, effective as of October 12, 2026. Mr. Tirman was designated by NYIAX, Inc. (“NYIAX”) in connection with Datavault AI's recently completed acquisition of NYIAX, and he previously served on NYIAX's board of directors. As a Datavault AI Shareholder, Mr. Tirman brings both an ownership perspective and extensive management experience to the Board.

Mr. Tirman has more than 35 years of international investment management experience, focused on corporate transformation, capital strategy and value creation. He has led complex cross-border transactions to strengthen balance sheets, reorganize operations and realign capital structures, both as a primary shareholder and on behalf of independent shareholders. His transaction experience includes public listings, private financings, spin-offs, acquisitions, balance sheet refinancings and creditor committee leadership.

“Jeffrey is joining our Board not just as an experienced director, but as a shareholder with real capital committed to Datavault AI’s success,” said Nathaniel Bradley, Chief Executive Officer of Datavault AI. “Jeffrey has spent more than three decades working with companies through critical periods of transformation, bringing a deep understanding of capital markets, corporate restructuring and strategic growth. His experience will be particularly valuable as we continue to expand our operations and evaluate opportunities to strengthen our financial position.”

Mr. Tirman currently serves as Chief Executive Officer of Elan d.o.o., a Slovenia-based sporting goods manufacturer, where he has led a comprehensive corporate restructuring and operational transformation following the company’s acquisition by institutional investors in 2015. His responsibilities have included financial stabilization, corporate reorganization, enhanced governance practices, management restructuring, operational improvements across four business divisions, multiple balance sheet refinancings and preparation of the business for a potential sale.

In 2016, Mr. Tirman founded Abri Capital Ltd., a private family-office investment firm investing globally across multiple asset classes and security types. Previously, he co-founded Rhodium Capital Management Ltd., a London-based investment manager specializing in European and CEEMEA credit markets. From 1997 to 2012, he served as President of Talisman Capital, managing investment strategies and corporate restructuring assignments for institutional clients across multiple industries. Mr. Tirman also served as an adjunct professor of Advanced Corporate Finance at HEC Lausanne from 2009 to 2014. He holds an MBA (Corporate Accounting) from Tulane University’s A.B. Freeman School of Business and a Bachelor of Business Administration (Economics) from the University of Arkansas at Little Rock.

“I am pleased to join Datavault AI’s Board at this critical stage in the Company’s development,” said Mr. Tirman. “As a shareholder, I have a vested interest in the Company’s success. My career has focused on helping businesses navigate complex financial and operational challenges, strengthening their capital structures and positioning themselves for profitable growth. I look forward to working with the company to support disciplined operational and financial execution and to grow the business in an intelligent manner.”

About Datavault AI

Datavault AI Inc. (Nasdaq: DVLT) is an AIP company focused on transforming data and real-world assets into intelligent, secure and monetizable digital assets. The Company’s integrated platform combines artificial intelligence, an AI-driven inference layer, data valuation, tokenization, cybersecurity, high-performance computing and exchange technologies to support the lifecycle of data and digital assets—from identification and valuation through tokenization, commercialization and monetization.

Datavault AI operates through two synergistic divisions: Data Science and Acoustic Science. The Data Science division includes the Company’s patented Data Vault®, DataValue® and DataScore® technologies, together with its cybersecurity, tokenization and exchange capabilities. The Acoustic Science division includes WiSA®, ADIO® and related spatial audio and data-over-sound technologies, as well as the Company’s events and experiential media businesses, including CompuSystems, Inc., operated under the Event Citadel brand, and API Media Innovations Inc.

Together, these capabilities form an integrated AI platform designed to connect data, intelligence, value and markets, enabling enterprises, institutions and asset owners to identify, protect, value and monetize data and real-world assets.

The Company is headquartered in Philadelphia, PA. For more information, visit www.dvlt.ai. Investor information is available at ir.datavaultsite.com. Technology news and insights are published at dvlt.ai/insights.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, and other applicable securities laws about Datavault AI Inc. (“Datavault AI,” the “Company,” “us,” “our,” or “we”) and our industry that involve risks and uncertainties. In some cases, you can identify forward-looking statements because they contain words, such as “may,” “might,” “will,” “shall,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” “goal,” “objective,” “seeks,” “likely” or “continue” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans or intentions. The absence of these words does not mean that a statement is not forward-looking.

Forward-looking statements in this press release include, but are not limited to, statements regarding the anticipated contributions of Jeffrey Tirman to the Company’s Board of Directors; the expected benefits of his investment management, corporate restructuring, capital markets and international business experience; the Company’s ability to strengthen its financial position, capital structure and strategic execution; the anticipated benefits of the Company’s acquisition of NYIAX; the Company’s ability to successfully integrate NYIAX’s business, personnel, intellectual property and technologies; the anticipated expansion, development, operation and commercialization of the Company’s exchange and tokenization platforms; the Company’s ability to leverage NYIAX’s patented exchange technology and contract management capabilities; the Company’s plans to expand its digital asset and data monetization businesses; and the Company’s future growth, strategic objectives and ability to create long-term shareholder value.

These forward-looking statements are based on the Company’s current expectations, estimates, assumptions and beliefs and are subject to numerous risks and uncertainties that could cause actual results, events or developments to differ materially from those expressed or implied by such statements. Such risks and uncertainties include, among others, the Company’s ability to successfully integrate NYIAX and realize the anticipated benefits of the acquisition; the ability of Jeffrey Tirman to contribute to the Company’s strategic and financial objectives; the ability of the Company’s Board of Directors and management team to effectively execute its strategic objectives; the Company’s ability to attract, retain and effectively utilize qualified directors, executives and other personnel; the Company’s ability to successfully develop, operate, integrate, scale and commercialize its exchange and tokenization technologies; technological, operational, cybersecurity, regulatory and other risks affecting the Company’s platforms and businesses; the availability, functionality and commercial adoption of the Company’s technologies; changes in market conditions and the competitive environment; the Company’s ability to strengthen its financial position; applicable federal and state securities laws and regulations and other laws and regulations applicable to digital assets, blockchain technologies and the Company’s businesses; and the other risks and uncertainties described in the Company’s filings with the U.S. Securities and Exchange Commission (“SEC”), including under the heading “Risk Factors” in the Company’s most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q and other filings with the SEC.

The forward-looking statements contained in this press release speak only as of the date of this press release. The Company undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by applicable law. Readers are cautioned not to place undue reliance on these forward-looking statements.

View source version on businesswire.com: https://www.businesswire.com/news/home/20261014349477/en/

Contacts

Media Contact
marketing@dvlt.ai

Investor Contact
Edward Barger
Vice President, Investor Relations
ir@dvlt.ai

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Responsible AI for Children: IEEE Delivers a Trusted Safety Formula to Help Protect Kids Online14.10.2026 15:00:00 EEST | Press release

The IEEE Standards Association, the global, consensus-building standards development organization of IEEE – the world’s largest technical professional organization and public charity dedicated to advancing technology for the benefit of humanity – today advanced its Responsible AI for Children (RAIC) Certification Program with the first product certified for children’s online safety. As children increasingly engage with digital and AI-enabled technologies, parents, educators, developers, and regulators want tools they can trust. IEEE’s Responsible AI for Children (RAIC) certification directly addresses these needs by translating global technical standards into a practical assessment for age-appropriate design and child safety – helping organizations prioritize children’s values, rights and well-being in their digital products and services. “As AI becomes part of children’s everyday lives, our responsibility as technology leaders has never been greater,” said Mary Ellen Randall, 2026 IEE

Debiopharm’s Pre-Clinical Proof-Of-Concept Research Unveils the Potential of Novel MultiLINK Linker Technology to Overcome Tumor Resistance14.10.2026 15:00:00 EEST | Press release

Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standards of care to cure cancer and infectious diseases, today announced their latest research on antibody drug conjugate (ADC) research released at World ADC San Diego 2026. Results highlighted the pre-clinical performance of a selection of linker technology from Debiopharm’s MultiLINK™ Linker Technology suite (MLINK Select, MLINK Duo and MLINK HiSol), revealing positive implications for the development of next generation ADCs and for the future of cancer patients that require more innovative therapies to overcome their disease. Despite remarkable progress in the ADC field, many cancers remain difficult to treat due to biological complexities that challenge current-generation therapies. Tumor heterogeneity can enable cancer cells with low or absent target expression to escape treatment, while acquired resistance to single-payload ADCs may emerge over time and compr

Takeda Presents Phase 2/3 IgGNITE Study Results of Investigational Subcutaneous TAK-881 in Primary Immunodeficiency Disease (PID) at ESID 202614.10.2026 15:00:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) announced detailed results from the pivotal Phase 2/3 IgGNITE clinical trial (TAK-881-3001) evaluating investigational TAK-881 [Immune Globulin Subcutaneous (Human), 20% Solution (SCIG 20%) and Recombinant Human Hyaluronidase], which, if approved, has the potential to become the first facilitated SCIG 20% therapy for patients with Primary Immunodeficiency Disease (PID) administered up to once-monthly (every 3 to 4 weeks). Data in participants aged 16 years and older are featured in two late-breaking posters at the 22nd Biennial Meeting of the European Society for Immunodeficiencies (ESID 2026) in Maastricht, the Netherlands. Previously shared topline results showed the clinical trial met its primary endpoint, demonstrating pharmacokinetic (PK) comparability between TAK-881 and HYQVIA® [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase]. Secondary analyses showed TAK-881 demonstrated infection outcomes and safety and tolerability profil

EZO Reaches Financial Close on €150 Million Senior Debt Facility14.10.2026 14:21:00 EEST | Press release

EZO has reached financial close on a €150 million investment-grade, non-recourse, senior debt facility. The funding will finance the design, installation, operation and maintenance of over 3,000 charge points, representing over 100,000 kWs of capacity, across the UK and Ireland under mostly long-term public sector “PPP-like” concessions with an attractive risk allocation between the public and private sector that will significantly advance EV infrastructure delivery, on time and to budget. These charge points are estimated to generate well in excess of £1 billion in electricity sales over the next 20 years, a portion of which will be shared with the public sector while, at the end of the concession, the chargers will revert back to the public sector. Headquartered in Ireland, EZO has expanded rapidly into the mainland UK, which by 2027 will become its primary EV charging market. The company is building the capital base, technology and operational capability required to deliver reliable

Compass Pathways Joins Forces with Leading Mental Health Organizations to Mark First-Ever U.S. Treatment-Resistant Depression (TRD) Awareness Day14.10.2026 13:30:00 EEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, today announced the first-ever TRD Awareness Day in the U.S., a day dedicated to recognizing and advocating for individuals, caregivers and communities impacted by TRD. The campaign is being amplified by leading mental health organizations, including National Alliance on Mental Illness (NAMI), Mental Health America (MHA) and the Depression and Bipolar Support Alliance (DBSA). TRD is a form of depression distinct from major depressive disorder (MDD) that is estimated to affect approximately 4 million people in the U.S., of whom fewer than 5% are currently on a TRD-indicated treatment.1,2,3 For many, the journey to recognizing TRD can involve years of cycling through antidepressant treatments that aren't providing meaningful relief, with an impact extending across work, school, relationships and daily life. TRD Awareness Day was established to i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye